Second-Generation CLL Inhibitors

http://youtu.be/QgHlPkBrXaE How could patients benefit from second-generation CLL inhibitors? CLL experts Dr. Nicole Lamanna and Dr. Philip Thompson explore the top three reasons researchers continue to push the envelope on inhibitors: safety, decreased side effects, and improved efficacy. Learn why Dr. Thompson describes clinical trials of second-generation medications as “more elegant, more refined.” Get email alerts | http://www.patientpower.info/alerts Subscribe on YouTube | http://www.youtube.com/patientpower Like on Facebook | http://www.fb.com/patientpower.info Follow on Twitter | http://www.twitter.com/patientpower Follow on Google+ | http://www.google.com/+patientpowerinfo